Other languages China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Delayed Nasdaq Other stock markets 08:27:16 21/05/2024 pm IST			5-day change	1st Jan Change
1.202 ^USD	-0.66%		+9.46%	-69.40%

05/04	China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	CI
08/02	Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	05/04
Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected	08/02
US Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade Data	08/02
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data	02/01
US Equity Futures Set Kick Off 2024 Lower Ahead of Manufacturing PMI, Construction Data	02/01
China SXT Pharmaceuticals to Implement 1-for-25 Reverse Stock Split	04/23/04
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	01/23/01
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2022	25/23/25
Top Premarket Gainers	05/22/05
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	18/22/18
China SXT Pharmaceuticals Effects 1-for-20 Reverse Stock Split; Shares Decline	18/22/18
China SXT Pharmaceuticals, Inc. Announces Resignation of Jingzhen Deng as Chief Scientific Officer and Chief Operation Officer	12/22/12
Health Care Fall Tuesday But Resist Steepest Declines	19/22/19
Sector Update: Health Care	19/22/19
China SXT Pharmaceuticals, Inc. Develops and Commercializes the Kuihuapan After-Soaking-Oral Tcmp and Zhudanfen Directly-Oral TCMP Products	15/22/15
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2021	15/22/15
China SXT Pharmaceuticals Receives Non-compliance Notice From Nasdaq	16/21/16
China SXT Pharmaceuticals : Secures Manufacturing Permit for Freeze Drying of Traditional Chinese Medicine Preparations; Shares Rise	18/21/18
China SXT Pharmaceuticals : Approves 1-for-4 Reverse Share Split; Shares Tumble Pre-Bell	19/21/19
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2020	29/21/29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Other languages

Filters